🚧 Website Under Construction - More Updates Coming Soon | الموقع ØªØØª الإنشاء - المزيد من Ø§Ù„ØªØØ¯ÙŠØ«Ø§Øª قريباً
Expert Health Technology Assessment, Pharmacoeconomic Modeling, and Statistical Analysis for Evidence-Based Policy Making
Empowering pharmaceutical companies and health authorities with evidence-based insights
Comprehensive evidence-based evaluation of health technologies including pharmaceuticals, medical devices, and diagnostic tools. We assess clinical effectiveness, cost-effectiveness, and broader societal impacts.
Advanced economic modeling to support healthcare decision-making. We develop sophisticated models to assess cost-effectiveness, budget impact, and value of pharmaceutical interventions.
Expert statistical consulting and advanced modeling for healthcare research. We transform complex data into actionable insights using cutting-edge analytical methods.
Strategic guidance on pharmaceutical policy, market access, and regulatory affairs. We help organizations navigate complex healthcare systems and align with global standards.
We combine international best practices with deep understanding of local healthcare systems to deliver solutions that drive real impact.
Following ISPOR, NICE, and international HTA guidelines
Leveraging enterprise-grade technology for healthcare innovation
Founder & Lead Consultant
As a dedicated researcher at the Egyptian Drug Authority (EDA), Maged Magdy brings unparalleled expertise in health technology assessment, pharmacoeconomics, and regulatory affairs to the pharmaceutical sector.
With extensive experience working with health ministries, pharmaceutical companies, and international organizations, Maged Magdy has been instrumental in shaping evidence-based healthcare policies and advancing the field of health economics in the region.
Let's discuss how our expertise can support your pharmaceutical decision-making and market access goals.